Ironwood Pharmaceuticals (IRWD)
(Real Time Quote from BATS)
$4.17 USD
-0.13 (-3.02%)
Updated Sep 23, 2024 11:56 AM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
Earnings News For IRWD
-
Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates
-
Ironwood: Q2 Earnings Snapshot
-
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2
-
Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
-
Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q2 Earnings Expected to Decline
-
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
-
Ironwood: Q1 Earnings Snapshot
-
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
-
Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
-
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
-
Ironwood: Q4 Earnings Snapshot
-
Ironwood: Q4 Earnings Snapshot
-
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
-
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
-
Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises
-
Ironwood: Q3 Earnings Snapshot
-
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
-
Why Is Ironwood (IRWD) Down 9.6% Since Last Earnings Report?
-
Ironwood Pharmaceuticals (IRWD) Q2 Earnings and Revenues Surpass Estimates
-
Ironwood: Q2 Earnings Snapshot
-
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS? U.S. Net Sales and Ironwood Revenue Guidance
-
Ironwood (IRWD) Q1 Earnings Beat Estimates, Linzess Volume Up
-
Ironwood Pharmaceuticals (IRWD) Surpasses Q1 Earnings and Revenue Estimates
-
Ironwood: Q1 Earnings Snapshot
-
Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance